These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6529986)

  • 1. [Derivatives of N-hydroxyfenfluramine and their anorectic activity].
    Bianchi M; Butti A; Dragonetti M
    Farmaco Sci; 1984 Dec; 39(12):1061-72. PubMed ID: 6529986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1-(2-Thienyl)-2-phenylethylamines as potential non-stimulant anorectics.
    Mrongovius RI; Ghosh P; Bolt AG; Ternai B
    Arzneimittelforschung; 1981; 31(10):1718-20. PubMed ID: 7198448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-anorectic activity relationships in substituted phenethylamines.
    Beregi SL; Duhault J
    Arzneimittelforschung; 1977; 27(1):116-8. PubMed ID: 576809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proceedings: The relationship between fenfluramine and norfenfluramine blood levels and anoretic activity in the rat.
    Blundell JE; Campbell DB
    Br J Pharmacol; 1975 Oct; 55(2):261P. PubMed ID: 1201401
    [No Abstract]   [Full Text] [Related]  

  • 5. Chemical and pharmacological studies of anorectic drugs with phenylpiperazinyl structure.
    Bermann MC; Berthelot P; Bonte JP; Debaert M; Lesieur D; Brunet C; Cazin M; Lesieur I; Luyckx M; Cazin JC
    Arzneimittelforschung; 1982; 32(6):604-10. PubMed ID: 7202364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of the anorectic activity of phenindamine d-amphetamine and fenfluramine in different species.
    Abdallah A; White HD
    Arch Int Pharmacodyn Ther; 1970 Dec; 188(2):271-83. PubMed ID: 5523473
    [No Abstract]   [Full Text] [Related]  

  • 7. 1,2-Diphenylethylamines as potential non-stimulant anorectics.
    Ghosh P; Bolt AG; Mrongovius RI
    Arzneimittelforschung; 1978; 28(9):1561-4. PubMed ID: 582555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The peripheral actions of antiobesity drugs.
    Turner P; Bichi LA; Slusarczyk H; Franklin CS
    Int J Obes; 1982; 6(4):411-5. PubMed ID: 6752061
    [No Abstract]   [Full Text] [Related]  

  • 9. Anorectic drugs and vitamin C: role in appetite and brain ascorbic acid in guineapigs.
    Odumosu A
    Int J Vitam Nutr Res; 1981; 51(3):247-53. PubMed ID: 7319724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central mechanisms of fenfluramine and related anorectic drugs.
    Garattini S
    Jpn J Pharmacol; 1981; 31 Suppl():29P-35P. PubMed ID: 7035726
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pharmacology of ITA 213, a producer of anorexic activity].
    Bermejo P; Beascoa E; Bargalló MA; Giráldez A; Bruseghini L
    Arch Farmacol Toxicol; 1978 Apr; 4(1):170-3. PubMed ID: 697390
    [No Abstract]   [Full Text] [Related]  

  • 12. Possible involvement of endogenous opiates in the tolerance to the anorectic effect of fenfluramine.
    Groppetti A; Parenti M; Dellavedova L; Tirone F
    J Pharmacol Exp Ther; 1984 Feb; 228(2):446-53. PubMed ID: 6694120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The metabolism in rat of tiflorex, a m-trifluoromethylthio-substituted phenylisopropylamine [proceedings].
    André JN; Dring LG; Gillet G; Mas-Chamberlin C
    Br J Pharmacol; 1979 Jul; 66(3):506P. PubMed ID: 526774
    [No Abstract]   [Full Text] [Related]  

  • 14. The selectivity of the anorectic effect of satietin. IV. The ineffectiveness of satietin on the sexual performance of male CFY rats.
    Yen TT; Dalló J; Knoll J
    Pol J Pharmacol Pharm; 1982; 34(1-3):41-5. PubMed ID: 6984758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evaluation of the anorectic activity in man of a sustained release formulation of tiflorex.
    Silverstone T; Fincham J; Plumley J
    Br J Clin Pharmacol; 1979 Apr; 7(4):353-6. PubMed ID: 444355
    [No Abstract]   [Full Text] [Related]  

  • 16. [Does fenfluramine mean a real advance in the treatment of obesity?].
    Chruściel M; Chruściel TL
    Postepy Hig Med Dosw; 1973; 27(3):365-90. PubMed ID: 4198497
    [No Abstract]   [Full Text] [Related]  

  • 17. Synthesis and anorectic activity of 2H-4,6-dimethyl-2-[(4- phenylpiperazin-1-yl)methyl]-3-oxo-2,3-dihydroisothiazolo[5,4-b]pyridin e.
    Malinka W; Rutkowska M
    Farmaco; 1997 Oct; 52(10):595-601. PubMed ID: 9507671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anorectic actions of the opiate antagonist naloxone.
    McCarthy PS; Dettmar PW; Lynn AG; Sanger DJ
    Neuropharmacology; 1981 Dec; 20(12B):1347-9. PubMed ID: 7322306
    [No Abstract]   [Full Text] [Related]  

  • 19. 1,3-Diaryltriazenes: a new class of anorectic agents.
    Hill DT; Stanley KG; Williams JE; Loev B; Fowler PJ; McCafferty JP; Macko E; Berkoff CE; Ladd CB
    J Med Chem; 1983 Jun; 26(6):865-9. PubMed ID: 6854589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies with flutiorex, a new anorectic drug, on glucose uptake into human isolated skeletal muscle.
    Kirby MJ; Carageorgiou-Markomihalakis H; Turner P
    Br J Clin Pharmacol; 1975 Dec; 2(6):541-2. PubMed ID: 1234019
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.